5-Methoxypsoralen increases the sensitivity of the retina to light in humans
- PMID: 2917589
- DOI: 10.1007/BF00561024
5-Methoxypsoralen increases the sensitivity of the retina to light in humans
Abstract
The acute effect of 5-methoxypsoralen (5-MOP) on the sensitivity of the retina to visible light in humans has been studied in 11 healthy volunteers 2 h after administration of 5-MOP or placebo given at 09.00 h. Retinal sensitivity was evaluated by electroretinography at 11.00 h. 5-MOP significantly increased the sensitivity of the retina to light under photopic conditions and in the early stages of the dark adaptation period, as observed under scotopic conditions. The findings suggest that melatonin is involved in these changes.
Similar articles
-
Melatonin decreases the amplitude of the b-wave of the human electroretinogram.Experientia. 1993 Aug 15;49(8):686-7. doi: 10.1007/BF01923951. Experientia. 1993. PMID: 8359274 Clinical Trial.
-
5-Methoxypsoralen increases the plasma melatonin levels in humans.J Invest Dermatol. 1987 Aug;89(2):152-5. doi: 10.1111/1523-1747.ep12470551. J Invest Dermatol. 1987. PMID: 3598208
-
5-Methoxypsoralen increases evening sleepiness in humans: possible involvement of the melatonin secretion.Eur J Clin Pharmacol. 1989;36(1):91-2. doi: 10.1007/BF00561032. Eur J Clin Pharmacol. 1989. PMID: 2917596 Clinical Trial.
-
5-Methoxypsoralen enhances plasma melatonin concentrations in the male rat: non-noradrenergic-mediated stimulation and lack of effect in pinealectomized animals.J Pineal Res. 1991 Aug;11(1):35-41. doi: 10.1111/j.1600-079x.1991.tb00824.x. J Pineal Res. 1991. PMID: 1941505
-
5-Methoxypsoralen inhibits 6-hydroxylation of melatonin in the rat.Biol Signals. 1995 Jan-Feb;4(1):32-41. doi: 10.1159/000109418. Biol Signals. 1995. PMID: 7550582
Cited by
-
Coumarin derivatives as anticancer agents targeting PI3K-AKT-mTOR pathway: a comprehensive literature review.Med Oncol. 2025 Jun 30;42(8):301. doi: 10.1007/s12032-025-02844-9. Med Oncol. 2025. PMID: 40587024 Review.
-
Melatonin decreases the amplitude of the b-wave of the human electroretinogram.Experientia. 1993 Aug 15;49(8):686-7. doi: 10.1007/BF01923951. Experientia. 1993. PMID: 8359274 Clinical Trial.
-
5-Methoxypsoralen. A review of its effects in psoriasis and vitiligo.Drugs. 1998 Oct;56(4):667-90. doi: 10.2165/00003495-199856040-00015. Drugs. 1998. PMID: 9806110 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources